Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayyan Hemetsberger

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trialMichael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
JAMA Cardiology|June 30, 2021
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical TrialJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trialMichael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
JAMA Cardiology|June 30, 2021
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical TrialJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 8